Abstract
Several novel antioxidant-iron chelators bearing 8-hydroxyoxyquinoline moiety were synthesized, and various properties related to their iron chelation, and neuroprotective action were investigated. All the chelators exhibited strong iron(III) chelating and high antioxidant properties. Chelator 9 (HLA20), having good permeability into K562 cells and moderate selective MAO-B inhibitory activity (IC50 110 microM), displayed the hightest protective effects against differentiated P19 cell death induced by 6-hydroxydopamine. EPR studies suggested that Chelator 9 also act as radical scavenger to directly scavenge hydroxyl radical.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alzheimer Disease / drug therapy*
-
Antioxidants / pharmacology
-
Cell Line
-
Cell Membrane Permeability / drug effects
-
Electron Spin Resonance Spectroscopy
-
Free Radical Scavengers / pharmacology
-
Humans
-
Iron Chelating Agents / chemical synthesis*
-
Iron Chelating Agents / chemistry
-
Iron Chelating Agents / pharmacology
-
Iron Chelating Agents / therapeutic use*
-
K562 Cells
-
Magnetic Resonance Spectroscopy
-
Mass Spectrometry
-
Monoamine Oxidase Inhibitors / pharmacology
-
Neurodegenerative Diseases / drug therapy*
-
Neuroprotective Agents / chemical synthesis*
-
Neuroprotective Agents / chemistry
-
Neuroprotective Agents / pharmacology
-
Neuroprotective Agents / therapeutic use*
-
Parkinson Disease / drug therapy*
Substances
-
Antioxidants
-
Free Radical Scavengers
-
Iron Chelating Agents
-
Monoamine Oxidase Inhibitors
-
Neuroprotective Agents